For the second year in a row, the average basic premium for a Medicare Part D plan will decline; a series of charts in The Wall Street Journal highlights what is driving US healthcare spending; taking a break from exercising can have metabolic consequences that linger for some people even after they return to their normal levels of exercise.
For the second year in a row, the average basic premium for a Medicare Part D plan will decline. According to CMS, Part D premiums are expected to fall from $33.59 in 2018 to $32.50 in 2019. In order to increase competition and drive down costs, CMS has introduced some changes, such as allowing for certain generic drugs to be substituted onto formularies more quickly and removing the requirement that certain Part D plans have to meaningfully differ from each other, which has made more plan options available and increased competition.
Healthcare costs in the United States are higher than other developed nations, but the cost isn’t high because Americans buy more healthcare. A series of charts in The Wall Street Journal highlighted what is driving US healthcare spending. Part of the issue is the opacity of the industry—patients don’t pay directly for services, instead the majority of health spending goes to paying for health insurance. The article highlighted the fact that consolidation also contributes to the overall increase in health costs.
Taking a break from exercising can have metabolic consequences that linger for some people even after they return to their normal levels of exercise, according to 2 new studies. The New York Times reported that the studies found that when volunteers reduced their daily step count and sat for more hours over the course of 2 weeks, their blood sugar levels rose and insulin resistance climbed. In addition, volunteers who started healthy began to lose muscle mass. Among volunteers who were older and already overweight, some had to be removed from the study because they “edged into full-blown type 2 diabetes.”
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Facilitators of and Barriers to Medicaid Investment in Electronic Consultation Services
March 5th 2025In this qualitative investigation, leaders of Medicaid managed care plans were interviewed to identify facilitators of and barriers to electronic consultation for specialty care delivery.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Facilitators of and Barriers to Medicaid Investment in Electronic Consultation Services
March 5th 2025In this qualitative investigation, leaders of Medicaid managed care plans were interviewed to identify facilitators of and barriers to electronic consultation for specialty care delivery.
Read More
2 Commerce Drive
Cranbury, NJ 08512